EGFR and non-small cell lung carcinoma: In NSCLC, long-term moderate hypoxia would elevate the expression of FGFR1 and maintain the MAPK activation, thereby promoting epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) resistance [13].